Updated : Apr 08, 2020 in Expert Pitch

Expert Q&A: Cancer, COVID-19 and Mental Health

LOS ANGELES (April 8, 2020) -- Cancer patients and survivors had a lot to deal with before the COVID-19 pandemic began. Now, the stress of…

Updated : Apr 06, 2020 in Research Articles

NUS researchers uncover hereditary mutation that drives aggressive head and neck, and lung cancers in Asian population

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have uncovered a genetic variant in a gene…

Updated : Apr 01, 2020 in Research Articles

Significant global investment could save 11 million children

A significant, sustained, global investment in treating children with cancer could save 11 million lives and yield a triple return on investment, according to a…

Updated : Apr 01, 2020 in Expert Pitch

CANCER AND COVID-19: Moffitt Cancer Center Experts & Resources

All individuals with weakened immune systems might be more susceptible to complications from COVID-19, and that means cancer patients are of particular concern. Moffitt Cancer…

Updated : Mar 30, 2020 in Research Articles

New blood test can detect wide range of cancers, now available to at risk individuals in clinical study at Dana-Farber

In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the…

Updated : Mar 30, 2020 in Research Articles

New therapeutic strategies proposed for some lung and kidney cancers

HOUSTON ― New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become “addicted” to glucose could…

Updated : Mar 26, 2020 in Research Articles

When Prostate Cancer Recurs, Adding Hormone Therapy to Radiation May Harm Men with Low PSA Levels

When cancer recurs after prostate surgery, adding long term hormone therapy to radiation therapy may do more harm than good for men with low PSA…

Updated : Mar 26, 2020 in Research Articles

Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer

Most ovarian cancer starts in fallopian tubes. Then it sloughs from its site of origin and floats around in fluid until finding new sites of…

Updated : Mar 26, 2020 in Feature Expert

How Errors in Divvying Up Chromosomes Lead to Defects in Cells

Note to our readers: Echoing the sentiments NIH Director Francis Collins made on his blog, the National Institute of General Medical Sciences (NIGMS) is making…

Updated : Mar 24, 2020 in Announcement

Dr. Mehra Golshan Appointed Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital and Yale Cancer Center

New Haven, Conn. — Mehra Golshan, M.D., M.B.A., F.A.C.S., has been appointed the inaugural Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital…

Updated : Mar 20, 2020 in Research Articles

Cancer Patients Over 65, on Multiple Medicines, Are at Higher Risk of Hospitalization

PHILADELPHIA – As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases…

Updated : Mar 19, 2020 in Feature

COVID-19 recommendations for patients receiving anti-cancer immunotherapies

We should all be doing our best to keep from catching COVID-19, if not for ourselves and our loved ones, then to avoid passing the…

Updated : Mar 12, 2020 in Research Articles

Statins Starve Cancer Cells to Death

More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers…

Updated : Mar 11, 2020 in Research Articles

Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer

When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was…

Updated : Mar 06, 2020 in Research Articles

Aggressive features in some small thyroid tumors increase the risk for metastasis

CHICAGO (March 6, 2020): Although papillary thyroid carcinoma is the most common form of thyroid malignancy, it is considered to be an indolent disease that…

Updated : Mar 06, 2020 in Announcement

Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19

NEW YORK, NY, CAMBRIDGE, MA, ROTTERDAM, NL, and SUZHOU, CN - Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted…

Updated : Mar 05, 2020 in Research Articles

New drug shows promise for treatment of cancer and other diseases

OMAHA, Ne. (Feb. 5, 2020) – The director of Creighton University’s Hereditary Cancer Center recently published research on a new drug that holds exciting possibilities for…

Updated : Feb 28, 2020 in Announcement

49 cancer care facilities receive outstanding achievement award from American College of Surgeons Commission on Cancer

CHICAGO (February 28, 2020): The Commission on Cancer (CoC) of the American College of Surgeons (ACS) has granted its 2019 Outstanding Achievement Award to a…

Updated : Feb 27, 2020 in Research Articles

Metabolic Pathway Can Be Effectively Targeted to Treat Prostate Cancer, Roswell Park Team Shows

  Research team identifies new approach to treating prostate cancer Metabolic targeting effective in lab study against aggressive prostate tumors Combining new, traditional approaches may…

Updated : Feb 27, 2020 in Research Articles

Cancer survival disparities in minority children, adolescents greater for more treatable cancers

Racial and ethnic minority children and adolescents with cancer have a higher risk of death than non-Hispanic white children and adolescents, with evidence for larger…

Updated : Feb 27, 2020 in Announcement

NCCN 2020 Annual Conference to Examine Advances in Cancer Care and Emerging Issues in Oncology

PLYMOUTH MEETING, PA and ORLANDO, FL [February 27, 2020] — Cancer care providers will gather in Orlando on March 20-22 for the National Comprehensive Cancer…

Updated : Feb 24, 2020 in Research Articles

“CRISPR: A Screener’s Guide” Headlines the March Edition of SLAS Discovery

For Immediate Release: February 24, 2020 Contact Information: Jill Hronek, Director of Marketing Communications Telephone: +1.630.256.7527, ext. 103 E-mail:  [email protected]  “CRISPR: A Screener’s Guide” Headlines…

Updated : Feb 20, 2020 in Feature

Saving Mother and Child

Five-year-old Emlee jumps high, runs fast and likes to pirouette around the living room in her white ballet slippers. Her mom, Karalayne Maglinte, calls her…

Updated : Feb 20, 2020 in Announcement

MD Anderson announces strategic collaboration with Denali Therapeutics to research and develop targeted therapies for neurodegenerative diseases

HOUSTON ― The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for…

Updated : Feb 20, 2020 in Feature

The Speed King

Greg Weiss, a backpack slung over his shoulder, walks through Aldrich Park. The professor of chemistry has just left a meeting at UCI’s Paul Merage…

Updated : Feb 20, 2020 in Research Articles

Yale Cancer Center Study Shows Long-Term Survival Benefit for Certain Patients with Advanced Lung Cancer

New Haven, Conn. — According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a…

Updated : Feb 20, 2020 in Feature

Gut Feelings

The long, winding river that is the human digestive tract is prone to all manner of diseases, from the merely irritable to the decidedly deadly.…

Updated : Feb 20, 2020 in Feature

Battling Brain Cancer on All Fronts

When you’re facing a cancer diagnosis with an average survival span of 12 to 18 months, every milestone is a victory. That makes each wedding…

Updated : Feb 20, 2020 in Feature

Beating Cancer – One Patient at a Time

Like most people, John Gifford wasn’t looking forward to a colonoscopy when he arrived on the UCI Medical Center campus in Orange in 2018. The…

Updated : Feb 19, 2020 in Research Articles

MicroRNA Exhibit Unexpected Function in Driving Cancer

PHILADELPHIA -- Researchers long thought that only one strand of a double-stranded microRNA can silence genes. Though recent evidence has challenged that dogma, it’s unclear…

Updated : Feb 19, 2020 in Research Articles

Controlling CAR T cells with light selectively destroys skin tumors in mice

Bioengineers at the University of California San Diego have developed a control system that could make CAR T-cell therapy safer and more powerful when treating…

Updated : Feb 18, 2020 in Research Articles

GI societies issue updated colorectal cancer screening recommendations

Bethesda, Maryland (Feb. 18, 2020) - Patients at average risk of colorectal cancer who have a normal colonoscopy do not need to repeat screening for…

Updated : Feb 18, 2020 in Feature

Speakers announced for 2020 Experimental Biology meeting

Renowned scientists including Nobel laureates, research pioneers and celebrated educators will convene at the Experimental Biology (EB) 2020 meeting, to be held April 4–7 in…

Updated : Feb 17, 2020 in Research Articles

New Computational Tools Identify Alternative Splicing Changes in Aggressive Cancers

Philadelphia, February 17, 2020—A multi-institutional group of researchers led by Children’s Hospital of Philadelphia(CHOP) has linked a strong cancer driver gene to changes in proteins…

Updated : Feb 17, 2020 in Research Articles

TARGETING TURNCOAT IMMUNE CELLS TO TREAT CANCER

FEBRUARY 17, 2020, NEW YORK — A Ludwig Cancer Research study has identified a mechanism by which regulatory T cells, which suppress immune responses, adapt…

Updated : Feb 15, 2020 in Research Articles

Cancer Immunotherapy Target Helps Fight Solid Tumors

SAN DIEGO, CA – Yvonne Chen engineers immune cells to target their most evasive enemy: cancer. New cancer immunotherapies generate immune cells that are effective…

Updated : Feb 15, 2020 in Research Articles

New High-Throughput Method to Study Gene Splicing at an Unprecedented Scale Reveals New Details About the Process

SAN DIEGO, CA – Genes are like instructions, but with options for building more than one thing. Daniel Larson, senior investigator at the National Cancer…

Updated : Feb 12, 2020 in Research Articles

CDI Lab Explores Pathway to Open up Blood Cancer Treatments

February 12, 2020, Nutley, NJ – Reversing runaway inflammation in the bone marrow could lead to major breakthroughs in treatments for some blood cancers, according…

Updated : Feb 12, 2020 in Research Articles

Designer Probiotic Treatment for Cancer Immunotherapy

Designer Probiotic Treatment for Cancer Immunotherapy  Columbia biomedical engineers have designed a novel probiotic strain that after a single dose can seek out solid tumors…

Updated : Feb 12, 2020 in Research Articles

Gay and bisexual men have higher rate of skin cancer

Boston, MA -- In the largest study of skin cancer rates among gay, lesbian or bisexual individuals, investigators from Brigham and Women's Hospital report important differences in…

Updated : Feb 11, 2020 in Research Articles

Prebiotics help mice fight melanoma by activating anti-tumor immunity

Prebiotics help mice fight melanoma by activating anti-tumor immunity LA JOLLA, CALIF. – Feb. 11, 2020 – Scientists at Sanford Burnham Prebys Medical Discovery Institute…

Updated : Feb 11, 2020 in Announcement

Dana-Farber Cancer Institute provides state-of-the-art oncology support services to Kronos employees through new company benefit

Dana-Farber Cancer Institute and Kronos Incorporated have joined forces to provide dedicated oncology care navigation services via a new benefit for Kronos employees and their…

Updated : Feb 10, 2020 in Research Articles

New Study Examines Ways to Improve Cancer Literacy in Young Students

LEXINGTON, Ky. (Feb. 10, 2020) – A new study led by University of Kentucky Markey Cancer Center researchers suggests that implementing cancer education curricula in middle and high…

Updated : Feb 10, 2020 in Research Articles

Statins May Lower Mortality in High-Risk Prostate Cancer Patients

PHILADELPHIA – Among high-risk prostate cancer patients – those with high PSA and Gleason scores of 8 or more – many will develop a difficult-to-treat…

Updated : Feb 10, 2020 in Research Articles

Human Gut-in-a-Dish Model Helps Define ‘Leaky Gut,’ and Outline a Pathway to Treatment

Once a vague scapegoat for a variety of ills, increasing evidence suggests a condition known as “leaky gut” — in which microbes and other molecules…

Updated : Feb 06, 2020 in Research Articles

Cancer-Causing Culprits Could be Caught by their DNA Fingerprints

Causes of cancer are being catalogued through an international study revealing the genetic fingerprints of DNA-damaging processes that drive cancer development. Researchers from University of…

Updated : Feb 05, 2020 in Research Articles

Study provides new understanding of mitochondria genome with potential for new avenues of treatment for multiple cancers

HOUSTON ― A study led by The University of Texas MD Anderson Cancer Center furthered understanding about mitochondria, the cell components known as the “powerhouse…

Updated : Feb 04, 2020 in Feature

Vanderbilt-Ingram Cancer Center Patient First for New Cell Engineering Platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.  The retired veterinarian, triathlete and…

Updated : Feb 03, 2020 in Research Articles

Cold plasma patch could make immunotherapy more effective for treating melanoma, study finds

Los Angeles - An interdisciplinary team of researchers at the UCLA Jonsson Comprehensive Cancer Center has developed a medicated patch that can deliver immune checkpoint inhibitors…

Updated : Jan 30, 2020 in Research Articles

Science Snapshot From Berkeley Lab – a biocompatible material that turns up the heat on antibacterial-resistant diseases

Photothermal therapy (PTT) – a proposed treatment for diseases such as antibacterial-resistant infections and cancer – makes use of a chemical agent that absorbs the…